Government Jobs

First class MSc. in Chemistry Physical, Analytical, Organic, Inorganic or related fields and have qualified National Eligibility Test conducted by CSIR-UGC NET JRF, LS MHRD GATE

Diploma in Pharmacy from a recognized University, Institution. Should be a registered Pharmacist under the Pharmacy Act, 1948. 02 Years of experience in related field. Kalyan Singh Super Specialty Cancer Institute, Lucknow KSSSCI invites online applications from the citizens of India for direct recruitment on various Non-teaching posts

Malabar Cancer Centre, Thalassery (MCC) is an autonomous institution under Health and Family Welfare Department, Government of Kerala, established under Societies Registration Act XXI of 1860.

B.Pharma or 12th in Science PCB with D.Pharma and registered as Pharmacist under the Pharmacy Act 1948. Minimum 03 years wok experience.

B. Pharm or 10+2 with Physics, Chemistry & Biology and Dip in Pharm. Min 3 years experience as a Pharmacist.

The candidate should have passed 10th, Higher Secondary, 10 plus 2 in science with recognized Diploma in Pharmacy, must be registered under Pharmacy Council Act and should have 02 years post qualification experience.

Professionals having proven competency and success in their area of specialization, with at least 10 years of post- qualification experience and should possess minimum M.Sc, B.Tech, BE, MCA, MPH, B.Pharm, BSMS, MD in AYUSH.

First Class M.Pharm, M.S. Pharm in Pharmaceutical Chemistry, Pharmaceutical Analysis, Medicinal Chemistry. Ability to design and execute independent research studies. Working knowledge of bioinformatic tools for the development of new synthetic compounds. Development of New Quinoxaline based 2-Pyrazolines as Potent and Selective MAO-A Inhibitors, In silico Studies, Synthesis and Biological Evaluation

M.Sc. Biotechnology, Microbiology or relevant life sciences discipline with a minimum of 55% marks. Minimum experience of two years as researcher. Establishment of synthetic antibody engineering platform for rapid development of indigenous bispecific antibodies to debilitate zoonotic pathogens reducing their pandemic potential.